{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:57:25Z","timestamp":1772639845172,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":4521,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1999,9]]},"abstract":"<jats:p>Streptococcal toxic shock syndrome (STSS) is caused by infection with a toxicogenic strain of <jats:italic>Streptococcus pyogenes<\/jats:italic>. Clinical manifestations may be those of a mild illness, characterized by malaise, fever, and muscle pain, to severe sepsis and multisystem organ failure. The syndrome may be associated with several invasive infections including necrotizing fasciitis. Treatment is primarily surgical debridement of infected tissue with supportive care, antibiotics, and hemodynamic monitoring. Intravenous immunoglobulin (IVIG) is reported to have beneficial effects in the management of STSS associated with necrotizing fasciitis. The agent was successful in conjunction with surgical excision and antibiotics in a patient with necrotizing fasciitis, toxic shock, and multisystem organ failure. On the basis of this experience and a thorough literature review, we concur that IVIG may be a useful adjunct in the treatment of STSS associated with necrotizing fasciitis.<\/jats:p>","DOI":"10.1592\/phco.19.13.1094.31589","type":"journal-article","created":{"date-parts":[[2004,5,7]],"date-time":"2004-05-07T06:14:36Z","timestamp":1083910476000},"page":"1094-1098","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Intravenous Immunoglobulin as Adjunctive Treatment for Streptococcal Toxic Shock Syndrome Associated with Necrotizing Fasciitis: Case Report and Review"],"prefix":"10.1002","volume":"19","author":[{"given":"Michael J.","family":"Cawley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Linwood R.","family":"Haith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen J.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Guilday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayna R.","family":"Braxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Lou","family":"Patton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707163170305"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.1.2"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198907063210101"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition","volume":"269","author":"The Working Group on Severe Streptococcal Infections","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91504-6"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480240077038"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549209054644"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.585"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.5.879"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06620.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.57.1.291-294.1989"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.1.232"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.4049\/jimmunol.150.6.2457","article-title":"Stimulation of human T cells by streptococcal \u201csuperantigen\u201d erythrogenic toxins (scarlet fever toxins)","volume":"150","author":"Braun MA","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199310001-00002"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92548-8"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.6.1469"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00304-X"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(06)80014-4"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02113510"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/514585"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/140.5.676"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of the type\u2010specific M antigens of group A streptococci","volume":"89","author":"Lancefield RL","year":"1962","journal-title":"J Immunol"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/iai.64.12.5395-5398.1996","article-title":"Evidence for the presence of streptococcal\u2010superantigen\u2010neutralizing antibodies in normal polyspecific immunoglobulin G","volume":"64","author":"Norrby\u2010Tegland A.","year":"1996","journal-title":"Infect Immun"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/514588"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/158.1.23"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110152"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.19.13.1094.31589","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.19.13.1094.31589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:29:58Z","timestamp":1761064198000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.19.13.1094.31589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["10.1592\/phco.19.13.1094.31589"],"URL":"https:\/\/doi.org\/10.1592\/phco.19.13.1094.31589","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,9]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}